Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Classificação em ações #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Preço da ação
$0.0009
Última sincronização: 2025-05-27
Valor de mercado
$1.15K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Arch Therapeutics, Inc. (ARTH)

Categoria

EPS de Arch Therapeutics, Inc. (ARTH)
EPS em June 2024 TTM: $-2.86
De acordo com os últimos relatórios financeiros e o preço das ações da Arch Therapeutics, Inc., o EPS atual da empresa (TTM) é $-2.86. No final de 2022, a empresa teve um EPS de $-3.56, uma diminuição em relação a ao EPS de 2021, que foi de $-5.97.
Histórico de EPS da Arch Therapeutics, Inc. de 2011 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-2.86 25.99%
2023 $-2.27 -36.24%
2022 $-3.56 -40.37%
2021 $-5.97 39.81%
2020 $-4.27 30.58%
2019 $-3.27 -48.10%
2018 $-6.30 -42.25%
2017 $-10.91 10.54%
2016 $-9.87 36.33%
2015 $-7.24 -70.00%
2014 $-24.13 114.11%
2013 $-11.27 766.92%
2012 $-1.30 1,424.03%
2011 $-0.09 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -705.59%
US
$27.74 -1,069.93%
NL
- -
CH
$13.70 -579.02%
BE
- -
KR